Safety and Immunogenicity of a Purified F Protein Respiratory Syncytial Virus (PFP‐2) Vaccine in Seropositive Children with Bronchopulmonary Dysplasia
Open Access
- 1 February 1998
- journal article
- clinical trial
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 177 (2) , 467-469
- https://doi.org/10.1086/517377
Abstract
Respiratory syncytial virus (RSV) causes serious respiratory illness in preterm children with bronchopulmonary dysplasia. In a prospective randomizedKeywords
This publication has 0 references indexed in Scilit: